Ginkgo Bioworks Holdings Price to Free Cash Flow Ratio 2020-2022 | DNA
Historical price to free cash flow ratio values for Ginkgo Bioworks Holdings (DNA) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Ginkgo Bioworks Holdings Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2023-02-03 |
2.06 |
|
0.00 |
| 2022-09-30 |
3.12 |
$-0.23 |
0.00 |
| 2022-06-30 |
2.38 |
$-0.21 |
0.00 |
| 2022-03-31 |
4.03 |
$-0.24 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.996B |
$0.314B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
